For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease
Visible fat loss lags behind internal improvements: Subcutaneous fat may shift slightly in weeks 412, but waist measurements and internal fat changes often take months to show
Melatonin signals circadian timing it tells your body when to sleep
*clinical T stage, clinical N stage only available for n = 11 patients
"The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying." Diabetes, Obesity and Metabolism
Do I need to cycle GHK-Cu or can I use it continuously